Use of ovarian reserve tests for the prediction of ongoing pregnancy in couples with unexplained or mild male infertility

Reproductive BioMedicine Online

Volumn 12, Issue 2, 2006, Pages 182-190

  van Rooij, Ilse A J ^a   Broekmans, Frank J M ^a   Hunault, Claudine C ^b   Scheffer, Gabriëlle J ^a   Eijkemans, Marinus J C ^b   de Jong, Frank H ^b   Themmen, Axel P N ^b   te Velde, Egbert R ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Age; AMH; Male infertility; Ongoing pregnancy; Ovarian reserve test; Unexplained infertility

Indexed keywords

ESTRADIOL; FOLLITROPIN; INHIBIN B; MUELLERIAN INHIBITING FACTOR; RECOMBINANT FOLLITROPIN;

ADULT; AGE; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FEMALE INFERTILITY; HORMONE DETERMINATION; HUMAN; INTRAUTERINE INSEMINATION; LAPAROSCOPY; MAJOR CLINICAL STUDY; MALE; MALE INFERTILITY; OBSERVATIONAL STUDY; OUTCOMES RESEARCH; PREDICTION; PREGNANCY; PREGNANCY RATE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; SPERMATOZOON MOTILITY; TRANSVAGINAL ECHOGRAPHY;

EID: 33144483525     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1472-6483(10)60859-0     Document Type: Article

References (57)

1. Bancsi LFJ, Broekmans FJM, Eijkemans MJC et al. 2002 Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertility and Sterility 77, 328-336.
2. Bancsi LF, Huijs AM, den Ouden CT et al. 2000 Basal follicle-stimulating hormone levels are of limited value in predicting ongoing pregnancy rates after in vitro fertilization. Fertility and Sterility 73, 552-557.
3. Bukman A, Heineman MJ 2001 Ovarian reserve testing and the use of prognostic models in patients with subfertility. Human Reproduction Update 7, 581-590.
4. Chang MY, Chiang CH, Chiu TH et al. 1998a The antral follicle count predicts the outcome of pregnancy in a controlled ovarian hyperstimulation/intrauterine insemination program. Journal of Assisted Reproduction and Genetics 15, 12-17.
5. Chang MY, Chiang CH, Hsieh TT et al. 1998b Use of the antral follicle count to predict the outcome of assisted reproductive technologies. Fertility and Sterility 69, 505-510.
6. Collins JA, Rowe TC 1989 Age of the female partner is a prognostic factor in prolonged unexplained fertility: a multicenter study. Fertility and Sterility 52, 15-20.
7. Collins JA, Burrows EA, Wilan AR 1995 The prognosis for live birth among untreated infertile couples. Fertility and Sterility 64, 22-28.
8. Creus M, Penarrubia J, Fabregues F et al. 2000 Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome. Human Reproduction 15, 2341-2346.
9. de Boer EJ, den Tonkelaar I, te Velde ER et al. 2002 A low number of retrieved oocytes at in vitro fertilization treatment is predictive of early menopause. Fertility and Sterility 77, 978-985.
10. De Felici M, Klinger FG, Farini D et al. 2005 Establishment of oocyte population in the fetal ovary: primordial germ cell proliferation and oocyte programmed cell death. Reproductive BioMedicine Online 10, 182-191.
11. de Vet A, Laven JSE, de Jong FH et al. 2002 Anti-Mullerian Hormone serum levels: A putative marker for ovarian aging. Fertility and Sterility 77, 357-362.
12. Dowell SF, Peeling RW, Boman J et al. 2001 Standardizing Chlamydia pneumonia assays: recommandations from the Centers of Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clinical Infectious Diseases 33,492-503.
13. Durlinger AL, Visser JA, Themmen AP 2002 Regulation of ovarian function: the role of anti-Mullerian hormone. Reproduction 124, 601-609.
14. Eimers JM, te Velde ER, Gerritse R et al. 1994 The prediction of the chance to conceive in subfertile couples. Fertility and Sterility 61, 44-52.
15. Evers JL, Slaats P, Land JA et al. 1998 Elevated levels of basal estradiol-17beta predict poor response in patients with normal basal levels of follicle-stimulating hormone undergoing in vitro fertilization. Fertility and Sterility 69, 1010-1014.
16. Fanchin R, Schonauer LM, Righini C et al. 2003 Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Human Reproduction 18, 323-327.
17. Galey-Fontaine J, Cédrin Durnerin I, Chaibi R et al. 2005 Age and ovarian reserve are distinct predictive factors of cycle outcome in low responders. Reproductive BioMedicine Online 10, 94-99.
18. Groome NP, Illingworth PJ, O'Brien M et al. 1996 Measurement of dimeric inhibin B throughout the human menstrual cycle. Journal of Clinical Endocrinology and Metabolism 81, 1401-1405.
19. Hall JE, Welt CK, Cramer DW 1999 Inhibin A and inhibin B reflect ovarian function in assisted reproduction but are less useful predicting outcome. Human Reproduction 14, 409-415.
20. Hazout A, Bouchard P, Seifer DB et al. 2004 Serum antimullerian hormone/ mullerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol. Fertility and Sterility 82, 1323-1329.
21. Hendriks DJ, Broekinans FJ, Bancsi LF et al. 2005 Repeated clomiphene citrate challenge testing in the prediction of outcome in IVF: a comparison with basal markers for ovarian reserve. Human Reproduction 20,163-169.
22. Hunault CC, Habbema JD, Eijkemans MJ et al. 2004 TWo new prediction rules for spontaneous pregnancy leading to live birth among subfertile couples, based on the synthesis of three previous models. Human Reproduction 19, 2019-2026.
23. Jager S, Kremer J, Slochteren-Draaisma T 1978 A simple method of screening for antisperm antibodies in the human male. Detection of spermatozoal surface IgG with the direct mixed antiglobulin reaction carried out on untreated fresh human semen. International Journal of Fertility 23, 12-21.
24. Jain T, Soules MR, Collins JA 2004 Comparison of basal follicle-stimulating hormone versus the clomiphene citrate challenge test for ovarian reserve screening. Fertility and Sterility 82, 180-185.
25. Johnson N, Vandekerckhove P, Watson A et al. 2002 Tubal flushing for subfertility. The Cochrane Database Systemic Reviews 3, CDO03718.
26. Kruger TF, Menkveld R, Stander FS et al. 1986 Sperm morphologic features as a prognostic factor in in vitro fertilization. Fertility and Sterility 46, 1118-1123.
27. Kumbak B, Oral E, Kahraman S et al. 2005 Young patients with diminished ovarian reserve undergoing assisted reproductive treatments: a preliminary report. Reproductive BioMedicine Online 11,294-299.
28. La Marca A, Malmusi S, Giulini S et al. 2004 Anti-Mullerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation. Human Reproduction 19, 2738-2741.
29. Lambalk CB 2003 Value of elevated basal follicle-stimulating hormone levels and the differential diagnosis during the diagnostic subfertility work-up. Fertility and Sterility 79, 489-490.
30. Land JA, Evers JL, Goossens VJ 1998 How to use Chlamydia antibody testing in subfertility patients. Human Reproduction 13, 1094-1098.
31. Leach RE, Moghissi KS, Randolph JF et al. 1997 Intensive hormone monitoring in women with unexplained infertility: evidence for subtle abnormalities suggestive of diminished ovarian reserve. Fertility and Sterility 68, 413-420.
32. Levi AJ, Raynault MF, Bergh PA et al. 2001 Reproductive outcome in patients with diminished ovarian reserve. Fertility and Sterility 76, 666-669.
33. Long WQ, Ranchin V, Pautier P et al. 2000 Detection of minimal levels of serum anti-Mullerian hormone during follow-up of patients with ovarian granulosa cell tumor by means of a highly sensitive enzyme-linked immunosorbent assay. Journal of Clinical Endocrinology and Metabolism 85, 540-544.
34. Loverro G, Nappi L, Mei L et al. 2003 Evaluation of functional ovarian reserve in 60 patients. Reproductive BioMedicine Online 7,200-204.
35. Magarelli PC, Pearlstone AC, Buyalos RP 1996 Discrimination between chronological and ovarian age in infertile women aged 35 years and older: predicting pregnancy using basal follicle stimulating hormone, age and number of ovulation induction/intra-uterine insemination cycles. Human Reproduction 11, 1214-1219.
36. Menkveld R, Wong WY, Lombard CJ et al. 2001 Semen parameters, including WHO and strict criteria morphology, in a fertile and subfertile population: an effort towards standardization of in-vivo thresholds. Human Reproduction 16, 1165-1171.
37. Mol BW, Dijkman B, Wertheim P et al. 1997 The accuracy of serum chlamydial antibodies in the diagnosis of tubal pathology: a meta-analysis. Fertility and Sterility 67, 1031-1037.
38. Muttukrishna S, Suharjono H, McGarrigle H et al. 2004 Inhibin B and anti-Müllerian hormone: markers of ovarian response in IVF/ICSI patients? British Journal of Obstetrics and Gynaecology 111, 1248-1253.
39. Ombelet W, Bosmans E, Janssen M et al. 1997 Semen parameters in a fertile versus subfertile population: a need for change in the interpretation of semen testing. Human Reproduction 12, 987-993.
40. Richardson SJ, Senikas V, Nelson JF 1987 Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion. Journal of Clinical Endocrinology and Metabolism 65, 1231-1237.
41. Scheffer GJ, Broekmans FJ, Bancsi LF et al. 2002 Quantitative transvaginal two- and three-dimensional sonography of the ovaries: reproducibility of antral follicle counts. Ultrasound Obstetrics Gynecology 20, 270-275.
42. Scott RT, Opsahl MS, Leonardi MR et al. 1995 Life table analysis of pregnancy rates in a general infertility population relative to ovarian reserve and patient age. Human Reproduction 10, 1706-1710.
43. Scott RT, Leonardi MR, Hofmann GE et al. 1993 A prospective evaluation of clomiphene citrate challenge test screening of the general infertility population. Obstetrics and Gynecology 82, 539-544.
44. Scott RT, Toner JP, Muasher SJ et al. 1989 Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertility and Sterility 51, 651-654.
45. Seifer DB, Lambert Messerlian G, Hogan JW et al. 1997 Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome. Fertility and Sterility 67, 110-114.
46. Sharif K, Elgendy M, Lashen H et al. 1998 Age and basal follicle stimulating hormone as predictors of in vitro fertilisation outcome. British Journal of Obstetrics and Gynaecology 105, 107-112.
47. Snick HK, Snick TS, Evers JL et al. 1997 The spontaneous pregnancy prognosis in untreated subfertile couples: the Walcheren primary care study. Human Reproduction 12, 1582-1588.
48. Steyerberg EW, Eijkemans MJ, Harrell FE Jr et al. 2000 Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data sets. Statistics in Medicine 19,1059-1079.
49. te Velde ER, Pearson PL 2002 The variability of female reproductive ageing. Human Reproduction Update 8, 141-154.
50. Toner JP, Philput CB, Jones GS et al. 1991 Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertility and Sterility 55, 784-791.
51. van Montfrans JM, Hoek A, van Hooff ME et al. 2000 Predictive value of basal follicle-stimulating hormone concentrations in a general subfertility population. Fertility and Sterility 74, 97-103.
52. Van Rooij IA, de long E, Broekmans FJ et al. 2004 High follicle-stimulating hormone levels should not necessarily lead to the exclusion of subfertile patients from treatment. Fertility and Sterility 81, 1478-1485.
53. Van Rooij IA, Bancsi LF, Broekmans FJ et al. 2003 Women older than 40 years of age and those with elevated follicle-stimulating hormone levels differ in poor response rate and embryo quality in in vitro fertilization. Fertility and Sterility 79, 482-488.
54. Van Rooij IA, Broekmans FJ, te Velde ER et al. 2002 Serum anti- Müllerian hormone levels: a novel measure of ovarian reserve. Human Reproduction 17, 3065-3071.
55. Watt AH, Legedza AT, Ginsburg ES et al. 2000 The prognostic value of age and follicle-stimulating hormone levels in women over forty years of age undergoing in vitro fertilization. Journal of Assisted Reproduction and Genetics 17, 264-268.
56. Weenen C, Laven JS, Von Bergh AR et al. 2004 Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Molecular Human Reproduction 10, 77-83.
57. World Health Organization 1992 WHO Manual for the Examination of Human Semen and Spenn-Cervical Mucus Interaction, 3rd edn. Cambridge University Press, Cambridge.